FABP4 and metabolic dysfunction-associated steatotic liver disease: The inflammatory activities of FABP4 in different immune cells has been reported previously in the context of obesity, atherosclerosis, nonalcoholic fatty liver disease and rheumatoid arthritis (RA) [7, 28, 29, 30].